Scientific R&D teams are under pressure to move faster without compromising rigor. We build customized, science-led solutions that help industries solve their hardest challenges, including:
We create reusable AI-enabled platforms that help scientists design, screen, predict, and validate molecules, materials, chemistries, and formulations faster — supporting scientific teams from hypothesis to validation through:
Discover why leading pharmaceutical companies choose Prescience Insilico
A 50+ member team with 30+ PhDs across computational sciences, engineering, chemistry, polymer science, materials science, catalysis, computational chemistry, and biology.
Trained at leading national and international institutions, including postdoctoral research experience, with a culture grounded in scientific rigor.
Expertise across formulation development, catalyst discovery, LLM building, materials informatics, generative AI, machine learning, and new material discovery and design.
10+ years of industrial and research experience supporting complex R&D programs and translating scientific insight into deployable industry solutions.
From problem framing, computational workflows, and model development to validation, deployment, and decision-making support.
Leverage advanced molecular simulations and ML models to identify high-affinity compounds with unprecedented accuracy and confidence.
These strengths translate into solutions that are scientifically rigorous, built quickly, scalable for enterprise R&D teams, and customized for the partners who use them.
Founded by a team of computational chemists, AI researchers, and pharmaceutical veterans, Prescience Insilico is dedicated to transforming R&D through intelligent automation and agentic AI.
Our mission is to compress scientific R&D timelines from decades to days by combining deep scientific expertise, advanced computation, and agentic AI to help industries solve complex discovery and innovation challenges.
Whether you are a researcher, engineer, early-career scientist, or business professional, this is where you can solve some of industry’s toughest scientific problems.
Explore case studies, whitepapers, and insights from our experts
The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has underscored the urgent need for effective antiviral therapeutics. One of the mos…
Read More →The Target Specific module within the SyMoG/AI application represents a groundbreaking approach to synthetic molecule generation tailored t…
Read More →In the modern era of computational drug discovery data is abundant but insights are priceless. The challenge is not gaining access to massi…
Read More →Metallo-β-lactamases (MBLs) are a critical group of enzymes that enable bacteria to resist β-lactam antibiotics, including carbapenems, whi…
Read More →Commencing on the fascinating world of in silico studies, our journey begins with the exploration and identification of protein targets. Ex…
Read More →The field of drug discovery is undergoing a transformative shift with the rise of PROTACs (Proteolysis Targeting Chimeras). These innovativ…
Read More →GK Co-Works (Managed Office Spaces)
72/12, Nallurahalli Main Rd, near shell petrol pump,
Whitefield, Siddapura, Brookefield, Bengaluru,
Karnataka 560066